Molecular Response, Efficacy and Safety Analysis of 168 Adult French Patients with Chronic Myeloid Leukemia (CML) in Chronic Phase (CP) From the ENACT (Expanding Nilotinib Access in Clinical Trials) Study.
暂无分享，去创建一个
J. Cayuela | M. Tulliez | A. Delmer | P. Rousselot | M. Berger | F. Guilhot | F. Nicolini | M. Duh | V. Coiteux | F. Maloisel | P. Lenain | D. Caillot | J. Cahn | T. Lamy | D. Bordessoule | F. Huguet | G. Étienne | A. Charbonnier | D. Réa | V. Dubruille | L. Legros | A. Guerci-Bresler | C. Belanger | H. Johnson-Ansah | T. Szczudlo | Jim Wang | M. Gardembas-pain